These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28286235)

  • 21. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
    Pizzorno A; Abed Y; Rhéaume C; Boivin G
    Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
    Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
    Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors.
    Tsai AW; McNeil CF; Leeman JR; Bennett HB; Nti-Addae K; Huang C; Germann UA; Byrn RA; Berlioz-Seux F; Rijnbrand R; Clark MP; Charifson PS; Jones SM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6007-16. PubMed ID: 26169418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of the oral neuraminidase inhibitor A-322278 against the oseltamivir-resistant H274Y (A/H1N1) influenza virus mutant in mice.
    Baz M; Abed Y; Nehmé B; Boivin G
    Antimicrob Agents Chemother; 2009 Feb; 53(2):791-3. PubMed ID: 19015327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets.
    Belser JA; Maines TR; Creager HM; Katz JM; Tumpey TM
    Virology; 2015 Oct; 484():305-312. PubMed ID: 26142497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice.
    Galabov AS; Simeonova L; Gegova G
    Antivir Chem Chemother; 2006; 17(5):251-8. PubMed ID: 17176629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome.
    Baranovich T; Burnham AJ; Marathe BM; Armstrong J; Guan Y; Shu Y; Peiris JM; Webby RJ; Webster RG; Govorkova EA
    J Infect Dis; 2014 May; 209(9):1343-53. PubMed ID: 24133191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection.
    Fukao K; Noshi T; Yamamoto A; Kitano M; Ando Y; Noda T; Baba K; Matsumoto K; Higuchi N; Ikeda M; Shishido T; Naito A
    J Antimicrob Chemother; 2019 Mar; 74(3):654-662. PubMed ID: 30476172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice.
    Burger RA; Billingsley JL; Huffman JH; Bailey KW; Kim CU; Sidwell RW
    Immunopharmacology; 2000 Apr; 47(1):45-52. PubMed ID: 10708809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of neuraminidase inhibitors for the treatment of Japanese patients infected with the novel influenza A (H1N1).
    Ohnishi K; Nakamura-Uchiyama F
    J Infect Chemother; 2010 Feb; 16(1):62-3. PubMed ID: 20072797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coadministration of Hedera helix L. Extract Enabled Mice to Overcome Insufficient Protection against Influenza A/PR/8 Virus Infection under Suboptimal Treatment with Oseltamivir.
    Hong EH; Song JH; Shim A; Lee BR; Kwon BE; Song HH; Kim YJ; Chang SY; Jeong HG; Kim JG; Seo SU; Kim H; Kwon Y; Ko HJ
    PLoS One; 2015; 10(6):e0131089. PubMed ID: 26098681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice.
    Shimizu T; Hino A; Tsutsumi A; Park YK; Watanabe W; Kurokawa M
    Antivir Chem Chemother; 2008; 19(1):7-13. PubMed ID: 18610553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of NH
    Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y
    Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficacy observation of atomization inhalation combined with oral administration of oseltamivir in 4 cases with H7N9 avian influenza].
    Li Z; Fu XY; Fang XB; Li J; Chen T; Qiu LM; Cai J; Wang WL; Pan ZQ; Zhang Y; Zhou JL
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(24):1883-1887. PubMed ID: 28648014
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.
    Kitano M; Kodama M; Itoh Y; Kanazu T; Kobayashi M; Yoshida R; Sato A
    Antimicrob Agents Chemother; 2013 May; 57(5):2286-94. PubMed ID: 23478960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
    Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
    Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of novel reassortant avian influenza H7N9 virus infection in vitro with three antiviral drugs, oseltamivir, peramivir and favipiravir.
    Cao RY; Xiao JH; Cao B; Li S; Kumaki Y; Zhong W
    Antivir Chem Chemother; 2014 Dec; 23(6):237-40. PubMed ID: 23948557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus.
    Julander JG; Hagloch J; Latimer S; Motter N; Dagley A; Barnard DL; Smee DF; Morrey JD
    Antiviral Res; 2011 Nov; 92(2):228-36. PubMed ID: 21867731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
    Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
    Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination activity of neuraminidase inhibitor oseltamivir and α-tocopherol in influenza virus A (H3N2) infection in mice.
    Galabov AS; Mileva M; Simeonova L; Gegova G
    Antivir Chem Chemother; 2015 Aug; 24(3-4):83-91. PubMed ID: 27341844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.